RTTNews | Aug 25, 2021 10:04AM EDT

10:04 Wednesday, August 25, 2021 (RTTNews.com) - Shares of Regencell Bioscience Holdings Limited (RGC) more than doubled on Wednesday morning despite no stock related news to drive the shares.

RGC is currently trading at $33.71, up $18.41 or 120.33%, on the Nasdaq, on a volume of 3.4 million shares, far above its average volume of 555 thousand shares. The stock has traded between $6.00 and $39.05 in the 52 week period. The stock value has nearly tripled in that time frame.

Regencell Bioscience operates a traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read the original article on RTTNews ( https://www.rttnews.com/3221049/regencell-bioscience-rally-continues-shares-up-120.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved